Studies of the Natural History, Pathogenesis, and Outcome of Idiopathic Systemic Vasculitis

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

Background: \- Vasculitis is a group of diseases that inflame and damage blood vessels and tissue. It can cause many medical problems. Few tests can diagnose the disease, and none can reliably predict a relapse. Researchers want to study people s genes and follow people over time to see how the disease affects them.

Objective: \- To learn the signs, symptoms, imaging tests, genetic markers, and blood tests that can help identify people with vasculitis and predict what will happen to them over time.

Eligibility: * People age 3 and older who have or are thought to have vasculitis, or are related to someone with it. * Healthy volunteers.

Design: * Participants will be evaluated by a doctor who has expertise caring for patients with vasculitis. * Participants will give a blood sample. Some will give a urine sample. * Some participants may have brushings or biopsies taken from the inside lining of the nose. * Images of participants blood vessels may be taken using scans. For some scans, participants will lie on a table that moves in and out of a cylinder that takes pictures. For some scans, a contrast agent may be injected into an arm vein. Other scans may use a radioactive form of sugar. Healthy minors will not have scans. * Some participants will answer questionnaires. - Some participants will have their tests done at NIH. Others will have their doctor take the blood, saliva, or cheek swab samples and send them to NIH. * Some participants will have one visit lasting 1-2 (but sometimes up to 4) days. Some participants may have follow-up visits every 3 - 6 months, indefinitely.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 3
Healthy Volunteers: t
View:

‣ SUBJECTS WITH VASCULITIS

⁃ Subjects who fulfill modified versions of the 1990 American College of Rheumatology (ACR) Classification Criteria for GPA31 and PAN

⁃ Subjects who fulfill the 1990 ACR Classification Criteria for EGPA, GCA, and TAK

⁃ Subjects who fulfill the 2012 Chapel Hill Nomenclature definition for MPA

⁃ Subjects with other suspected systemic or single-organ vasculitides

‣ HEALTHY VOLUNTEERS

• Volunteers able to provide consent, or in the case of minors, assent

Locations
United States
Maryland
National Institutes of Health Clinical Center
RECRUITING
Bethesda
Contact Information
Primary
Wendy Goodspeed, R.N.
goodspew@mail.nih.gov
(301) 451-6761
Backup
Peter C Grayson, M.D.
peter.grayson@nih.gov
(240) 731-4558
Time Frame
Start Date: 2014-09-29
Estimated Completion Date: 2050-01-01
Participants
Target number of participants: 4000
Treatments
Healthy Volunteers
Patients without known auto immune diseases
Vasculitis
Patients with known or suspected vasculitis age 5 or older
Sponsors
Leads: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

This content was sourced from clinicaltrials.gov